Liraglutide improves cognitive impairment via the AMPK and PI3K/Akt signaling pathways in type 2 diabetic rats

Ying Yang(Nanjing Tech University), Jing Xu(Tangshan Gongren Hospital)
Molecular Medicine Reports
June 18, 2018
Cited by 73


Related Papers